• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.54% Nasdaq Down1.52%

    Meridian Bioscience, Inc. (VIVO)

    -NasdaqGS
    18.59 Down 0.33(1.74%) Apr 17, 4:00PM EDT
    |After Hours : 18.59 0.00 (0.00%) Apr 17, 4:37PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 48,013   46,692   47,212   50,134  
    Cost of Revenue18,776  18,291  17,970  18,541  
    Gross Profit 29,237   28,401   29,242   31,593  
    Operating Expenses
    Research Development3,103  3,367  3,146  3,186  
    Selling General and Administrative13,465  13,066  12,964  12,741  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 12,669   11,968   13,132   15,666  
    Income from Continuing Operations
    Total Other Income/Expenses Net(576)206  (252)(22)
    Earnings Before Interest And Taxes12,093  12,174  12,880  15,644  
    Interest Expense -   -   -   -  
    Income Before Tax12,093  12,174  12,880  15,644  
    Income Tax Expense4,192  3,992  4,045  5,344  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops7,901  8,182  8,835  10,300  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 7,901   8,182   8,835   10,300  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 7,901   8,182   8,835   10,300  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.